Loading people...
David Rabuka is a Venture Capitalist at the Berkeley Catalyst Fund, where he focuses on early-stage investments in innovative companies, particularly those emerging from the UC Berkeley ecosystem.
David Rabuka primarily invests in deep technology, life sciences, advanced materials, engineering, and software solutions. He seeks out early-stage ventures with strong scientific foundations and potential for significant impact, often originating from UC Berkeley research.
David Rabuka works as a Venture Capitalist at the Berkeley Catalyst Fund, an organization dedicated to supporting and investing in startups connected to the UC Berkeley innovation ecosystem.
David Rabuka is the Co-founder and CEO of Acrigen Biosciences and a Venture Partner at the Berkeley Catalyst Fund, based in the San Francisco Bay Area. He previously founded Redwood Bioscience in 2008, serving as its President and Chief Scientific Officer until its 2014 acquisition by Catalent. Following this transaction, he operated as the Global Head of Research and Development for Chemical Biology at Catalent, advancing the SMARTag antibody-drug conjugate platform. He holds a doctorate in chemistry from UC Berkeley and has authored multiple peer-reviewed publications in the biotechnology space. As an active venture investor, he targets early-stage life sciences and energy technology startups with initial check sizes ranging from $100,000 to $5 million. Rabuka currently focuses on translating novel chemical biology technologies into clinical therapies, specifically through the development of precision CRISPR gene-editing therapeutics.
David Rabuka is a distinguished Venture Capitalist at the Berkeley Catalyst Fund, an organization deeply committed to fostering innovation within the UC Berkeley community and beyond. In his role, Rabuka is instrumental in sourcing, evaluating, and investing in promising early-stage companies that leverage cutting-edge research and intellectual property originating from the university's renowned labs and entrepreneurial talent. His work at Berkeley Catalyst Fund directly supports the commercialization of transformative technologies, bridging the gap between academic discovery and market-ready solutions.
Rabuka's investment focus at the Berkeley Catalyst Fund is broad yet strategic, primarily targeting deep technology, life sciences, advanced materials, engineering, and software solutions. He seeks out ventures that demonstrate strong scientific foundations, defensible intellectual property, and scalable business models. A key aspect of his investment philosophy involves identifying founders with a clear vision and the drive to disrupt established industries or create entirely new markets. David Rabuka is particularly interested in companies that not only promise financial returns but also offer significant societal impact, aligning with the fund's mission to support ventures that contribute positively to the world.
While specific details of David Rabuka's career background are not publicly detailed, his position as a Venture Capitalist at a university-affiliated fund suggests a robust background in technology commercialization, startup operations, or a strong scientific/engineering foundation. Professionals in this space often bring experience from previous entrepreneurial endeavors, corporate development roles, or scientific research, equipping them with the unique perspective needed to evaluate complex technical innovations and guide nascent companies through their critical early growth phases. This blend of technical acumen and business insight is crucial for success in the deep tech investment landscape.
The Berkeley Catalyst Fund, under the guidance of investors like David Rabuka, has a track record of backing ventures that emerge from UC Berkeley's rich research environment. While specific individual investments by David Rabuka are not typically publicized, the fund's portfolio generally includes companies poised to revolutionize sectors ranging from biotechnology and sustainable energy to artificial intelligence and advanced manufacturing. These investments are characterized by their strong ties to university research and their potential for significant market disruption. David Rabuka's efforts contribute to the fund's mission of accelerating the growth of these high-potential startups, providing not just capital but also strategic guidance and access to a vast network of industry experts and mentors.
